Monsanto Opens First Biotechnology Research Center in China
The new research center is an extension of the company's commitment to doubling yields in its core crops by 2030 compared to a base year of 2000, while reducing the amount of inputs required per unit produced by a third. Monsanto currently invests more than $2 million a day in research in order to meet this commitment to global agriculture.
The Beijing research center will participate in early-stage bioinformatics and genomics research, and serve as a base for collaborations with Chinese scientists. Monsanto also has research centers in the United States, Brazil and India.
"Monsanto has made a commitment to collaborate with Chinese scientists on advanced biotech and breeding technology," said Stephen Padgette, vice president of biotechnology for Monsanto. "Monsanto has made a commitment to develop advanced biotech and breeding technology to China. The establishment of the center will give Chinese researchers access to our global research network and to our industry-leading product development pipeline."
Most read news
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.